fundmomentum.vc

Catalio Nexus Fund IV

United States
Pre Seed
Share

About Catalio Nexus Fund IV

Catalio Nexus Fund IV is a venture capital firm based in United States, focusing on Pre-Seed stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited States
Funding StagePre Seed
Industry Focus
Deep Tech
Saas

Investor Signals Profile

active

Sweet Spot

Enterprise SaaS founders solving legacy modernization with AI

Enterprise AI
Legacy modernization
Knowledge management
SaaS tooling
Digital transformation
Biotech AI
Clinical imaging
Pulmonary disease imaging

Bullish Signals

3 Fortune 500 CIOs on advisory boardexternal
40% faster migrations — early adopter dataexternal
90% AI code gen accuracy claimedexternal
Native connectors: Salesforce, ServiceNow, NetSuiteexternal
NOETIK GSK 5-year oncology partnership dealcatalio_linkedin
Clinical imaging AI selecting trial patientscatalio_linkedin
Avalyn Phase 2b: 70% fibrosis stabilized/reversedcatalio_linkedin
150+ patient imaging dataset, 5-year lung function holdcatalio_linkedin

Contrarian Signals

Metrics based on early adopters onlyexternal
No named VC backers disclosedexternal
Advisory-heavy, no listed founding teamexternal

Founder Do's

Target enterprise legacy system pain
Show AI-powered automation metrics
Highlight migration speed & accuracy
Lead with institutional knowledge loss
Have enterprise security story ready
Demonstrate pharma/biotech AI partnerships
Show imaging AI clinical trial validation

Founder Don'ts

Don't pitch generic documentation tools
Don't ignore compliance/security requirements
Don't skip migration ROI proof points

Key GPs & Partners

WS
Wayne Shurts
Advisory Board
Enterprise veteranCIO Hall of FameBoard Director
JW
Jonathan C. Williams
Advisory Board
Serial entrepreneurCTO advisorPE-backed
WS
Wesley Story
Advisory Board
Transformational CIOCloud modernizationGlobal scale
RA
Ron Alfa
Co-Founder & CEO
MD/PhD biotechAI-driven oncologyGSK partnership
LB
Lyn Baranowski
CEO
Pulmonary fibrosis expertClinical trial leaderNASDAQ biotech

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund Size$400M
Saves0
Website
LinkedIn

Key People

George Etrocheilos, Dr. Jacob Vogelstein

Wayne ShurtsAdvisory Board
Jonathan C. WilliamsAdvisory Board
Wesley StoryAdvisory Board
Ron AlfaCo-Founder & CEO
Lyn BaranowskiCEO

Related Funds

ResilienceVC (I)

$56M
United States
Pre Seed
Saas
Fund Manager:Tahira Dosani, Vikas Raj
Pre Seed
Saas

Wave Function Ventures Fund I

$15M
United States
Pre Seed
Deep Tech, Space, Defense, Energy Tech, Robotics Automation, Infrastructure Tech
Fund Manager:Jamie Gull
Pre Seed
Deep Tech
Space
Defense
Energy Tech
Robotics Automation
Infrastructure Tech

Forward Deployed Venture Capital Fund II

$45M
United States
Seed
Defense, Manufacturing, Infrastructure Tech, Ai Ml
Fund Manager:Mark Scianna
Seed
Defense
Manufacturing
Infrastructure Tech
Ai Ml